Energy devices, biostimulators, fillers, lasers, and clinical aesthetic protocols.
Mechanism, efficacy data, downtime, and the post-inflammatory hyperpigmentation risk that dominates ablative fractional CO2 resurfacing for atrophic acne scars, with a focus on darker and Asian skin.
How microfocused ultrasound, monopolar radiofrequency, and RF microneedling differ for skin tightening, and how clinicians choose the right energy-based option.
Do exosome skin treatments work? Reviews find encouraging short-term signals, but mostly non-randomized studies and unresolved long-term safety gaps remain.
After rapid weight loss on GLP-1 drugs, loose skin on the abdomen, arms, and thighs is common. What the evidence says about energy-based tightening, biostimulators, timing, and when surgery is the realistic option.
What 41 studies show about RF microneedling efficacy, how devices differ, and why the FDA's 2025 serious-complication reports limit broad safety claims.
Why GLP-1 receptor agonists cause facial volume loss, severity predictors, and the published multimodal restoration approaches in 2026.
What polynucleotide injectables do, what the systematic review data shows, how they compare with HA boosters, adverse events, and patient selection.
Mechanism of collagen induction, expected timeline, reconstitution evidence, recognized complications, and patient selection for PLLA.
Mechanism, timeline, comparator data vs MFU-V, adverse events, and patient selection for monopolar radiofrequency facial tightening.
MFU-V means microfocused ultrasound with visualization in aesthetic medicine. Review skin-tightening results, safety, timelines, and patient selection.